Clinical trial
Evaluation of the Efficacy and Safety of the Local Treatment of Carboxymethyl Beta-glucan and Polycarbophil in Patients With Normal Cytology/ASCUS/LSIL (CIN1) With HPV+ PCR Determination
NCT06199128 is registered in ClinicalTrials.gov with Uriach Consumer Healthcare as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Evaluation of the Efficacy and Safety of the Local Treatment of Carboxymethyl Beta-glucan and Polycarbophil in Patients With Normal Cytology/ASCUS/LSIL (CIN1) With HPV+ PCR Determination
- Lead sponsor
- Uriach Consumer Healthcare
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 22, 2022
- Completion date
- November 22, 2023
- Enrollment
- 533 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
human papillomavirus infection